<DOC>
	<DOCNO>NCT01042353</DOCNO>
	<brief_summary>- Background : Ventilator-acquired pneumonia ( VAP ) prevalent nosocomial infection intensive care unit ( ICUs ) . Early microbiological diagnosis initial administration appropriate antimicrobial therapy associate well outcome . Broad-spectrum antibiotic therefore administer initially . However , inconsiderate antibiotic use increase prevalence multi-resistant bacteria . - Purpose : A rapid antimicrobial susceptibility method require decrease unnecessary use empirical broad-spectrum antibiotic . The aim study compare efficiency rapid antibiogram , provide E-test strip directly apply bronchoalveolar lavage ( BAL ) sample analyse 24 h , obtain standard method culture provide later result . - Study design : This open-label , prospective cohort study consecutive patient VAP , conduct medical ICU . In addition standard culture method , E-test perform directly BAL sample analyse 24 h. Each standard BAL culture use control E-test method . - Primary outcome : The occurrence major error , define isolates determine susceptible E-test resistant standard culture method . - Secondary outcome : The occurrence minor error ( define isolates determine resistant E-test susceptible standard method ) , comparison two method seed BAL sample Mueller Hinton agar plate ( swab method , flood method ) . - Eligibility criterion : - Inclusion criterion : patient suspect VAP ( define Clinical Pulmonary Infection Score ≥5 ) undergo BAL eligible . - Exclusion criterion : contraindication BAL ( PaO2/FIO2 &lt; 100 , risk bronchoscopy-related haemorrhagic complication ) , secondary exclusion patient negative culture , define threshold bacteria &lt; 104 CFU/ml . - Interventions : BAL sample culture standard method minimal inhibitory concentration ( MIC ) bacteria usual antibiotic determine use standard procedure . At time BAL collection , rapid antibiogram perform place E-test antibiotic strip ( AB Biodisk ) directly onto Mueller-Hinton agar plate seed BAL specimen ( flood swab ) . E-test strip impregnate cefoxitin , piperacillin-tazobactam , cefepime , imipenem , ciprofloxacin amikacin . At 24 h , E-test plat photograph examine separately bacteriologist medical ICU physician follow consensus method . The final E-test result compare standard MIC culture .</brief_summary>
	<brief_title>Direct E-test Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<criteria>patient suspect VAP ( define Clinical Pulmonary Infection Score ≥5 ) undergo BAL eligible . contraindication BAL ( PaO2/FIO2 &lt; 100 , risk bronchoscopyrelated haemorrhagic complication ) , secondary exclusion patient negative culture , define threshold bacteria &lt; 104 CFU/ml .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>